Approximately 60% of melanomas contain BRAF proto-oncogene mutations, with the most common being the valine-to-glutamic acid substitution at codon 600 (BRAFV600E), which leads to the abnormal activation of MAPK signaling (Davies et al., 2002; Holderfield et al., 2014). This evidence concerns the gene BRAF and melanoma.